Stock overview
Mineralys Therapeutics Inc.
Explore the company, reported ownership, price history, and available source evidence.
MINERALYS THERAPEUTICS INC (MLYS) is a healthcare or biotechnology equity security tracked from 13F filings.
- Last close
- $25.86
- · MLYS
- Tracked holders
- 2 funds
- Latest available 13F per fund
MLYS · USD
Price
$25.86
+$7.42
(+40.24%)
over selected range
Close · Sep 25, 2026
Market closed
909 stored daily closes
$25.86
Sep 25, 2026
- Range low
- $5.96
- Range high
- $47.33
- Observations
- 909
- Session date
- Sep 25, 2026
Feb 10, 2023–Sep 25, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Tudor Investment Corp largest tracked holder Q2 2026 · filed Aug 14, 2026 · SEC filing | +374% 26'Q2 | $19,921,223 | 0.03% |
| Renaissance Technologies position history Q2 2026 · filed Aug 13, 2026 · SEC filing | −1% 26'Q2 | $10,206,534 | 0.01% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market